Hypothalamic deep brain stimulation in the treatment of chronic cluster headache

Massimo Leone, Angelo Franzini, Alberto Proietti Cecchini, Giovanni Broggi, Gennaro Bussone

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Cluster headache (CH) is a short-lasting unilateral headache associated with ipsilateral craniofacial autonomic manifestations. A positron emission tomography (PET) study has shown that the posterior hypothalamus is activated during CH attacks, suggesting that hypothalamic hyperactivity plays a key role in CH pathophysiology. On this basis, stimulation of the ipsilateral posterior hypothalamus was hypothesized to counteract such hyperactivity to prevent intractable CH. Ten years after its introduction, hypothalamic stimulation has been proved to successfully prevent attacks in more than 60% of 58 hypothalamic implanted drug-resistant chronic CH patients. The implantation procedure has generally been proved to be safe, although it carries a small risk of brain haemorrhage. Long-term stimulation is safe, and nonsymptomatic impairment of orthostatic adaptation is the only noteworthy change. Microrecording studies will make it possible to better identify the target site. Neuroimaging investigations have shown that hypothalamic stimulation activates ipsilateral trigeminal complex, but with no immediate perceived sensation within the trigeminal distribution. Other studies on the pain threshold in chronically stimulated patients showed increased threshold for cold pain in the distribution of the first trigeminal branch ipsilateral to stimulation. These studies suggest that activation of the hypothalamus and of the trigeminal system are both necessary, but not sufficient to generate CH attacks. In addition to the hypothalamus, other unknown brain areas are likely to play a role in the pathophysiology of this illness. Hypothalamus implantation is associated with a small risk of intracerebral haemorrhage and must be performed by an expert neurosurgical team, in selected patients.

Original languageEnglish
Pages (from-to)187-195
Number of pages9
JournalTherapeutic Advances in Neurological Disorders
Volume3
Issue number3
DOIs
Publication statusPublished - May 2010

Fingerprint

Cluster Headache
Deep Brain Stimulation
Posterior Hypothalamus
Hypothalamus
Pain Threshold
Therapeutics
Headache Disorders
Intracranial Hemorrhages
Cerebral Hemorrhage
Neuroimaging
Positron-Emission Tomography
Headache
Brain
Pharmaceutical Preparations

Keywords

  • Chronic cluster headache
  • Deep stimulation
  • Drug-resistant
  • Hypothalamus
  • Neuromodulation
  • Neurostimulation
  • Trigeminal autonomic cephalgias

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Pharmacology

Cite this

Hypothalamic deep brain stimulation in the treatment of chronic cluster headache. / Leone, Massimo; Franzini, Angelo; Proietti Cecchini, Alberto; Broggi, Giovanni; Bussone, Gennaro.

In: Therapeutic Advances in Neurological Disorders, Vol. 3, No. 3, 05.2010, p. 187-195.

Research output: Contribution to journalArticle

Leone, Massimo ; Franzini, Angelo ; Proietti Cecchini, Alberto ; Broggi, Giovanni ; Bussone, Gennaro. / Hypothalamic deep brain stimulation in the treatment of chronic cluster headache. In: Therapeutic Advances in Neurological Disorders. 2010 ; Vol. 3, No. 3. pp. 187-195.
@article{618d536fc3e5440cbd5e59dea40e66d1,
title = "Hypothalamic deep brain stimulation in the treatment of chronic cluster headache",
abstract = "Cluster headache (CH) is a short-lasting unilateral headache associated with ipsilateral craniofacial autonomic manifestations. A positron emission tomography (PET) study has shown that the posterior hypothalamus is activated during CH attacks, suggesting that hypothalamic hyperactivity plays a key role in CH pathophysiology. On this basis, stimulation of the ipsilateral posterior hypothalamus was hypothesized to counteract such hyperactivity to prevent intractable CH. Ten years after its introduction, hypothalamic stimulation has been proved to successfully prevent attacks in more than 60{\%} of 58 hypothalamic implanted drug-resistant chronic CH patients. The implantation procedure has generally been proved to be safe, although it carries a small risk of brain haemorrhage. Long-term stimulation is safe, and nonsymptomatic impairment of orthostatic adaptation is the only noteworthy change. Microrecording studies will make it possible to better identify the target site. Neuroimaging investigations have shown that hypothalamic stimulation activates ipsilateral trigeminal complex, but with no immediate perceived sensation within the trigeminal distribution. Other studies on the pain threshold in chronically stimulated patients showed increased threshold for cold pain in the distribution of the first trigeminal branch ipsilateral to stimulation. These studies suggest that activation of the hypothalamus and of the trigeminal system are both necessary, but not sufficient to generate CH attacks. In addition to the hypothalamus, other unknown brain areas are likely to play a role in the pathophysiology of this illness. Hypothalamus implantation is associated with a small risk of intracerebral haemorrhage and must be performed by an expert neurosurgical team, in selected patients.",
keywords = "Chronic cluster headache, Deep stimulation, Drug-resistant, Hypothalamus, Neuromodulation, Neurostimulation, Trigeminal autonomic cephalgias",
author = "Massimo Leone and Angelo Franzini and {Proietti Cecchini}, Alberto and Giovanni Broggi and Gennaro Bussone",
year = "2010",
month = "5",
doi = "10.1177/1756285610370722",
language = "English",
volume = "3",
pages = "187--195",
journal = "Therapeutic Advances in Neurological Disorders",
issn = "1756-2856",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - Hypothalamic deep brain stimulation in the treatment of chronic cluster headache

AU - Leone, Massimo

AU - Franzini, Angelo

AU - Proietti Cecchini, Alberto

AU - Broggi, Giovanni

AU - Bussone, Gennaro

PY - 2010/5

Y1 - 2010/5

N2 - Cluster headache (CH) is a short-lasting unilateral headache associated with ipsilateral craniofacial autonomic manifestations. A positron emission tomography (PET) study has shown that the posterior hypothalamus is activated during CH attacks, suggesting that hypothalamic hyperactivity plays a key role in CH pathophysiology. On this basis, stimulation of the ipsilateral posterior hypothalamus was hypothesized to counteract such hyperactivity to prevent intractable CH. Ten years after its introduction, hypothalamic stimulation has been proved to successfully prevent attacks in more than 60% of 58 hypothalamic implanted drug-resistant chronic CH patients. The implantation procedure has generally been proved to be safe, although it carries a small risk of brain haemorrhage. Long-term stimulation is safe, and nonsymptomatic impairment of orthostatic adaptation is the only noteworthy change. Microrecording studies will make it possible to better identify the target site. Neuroimaging investigations have shown that hypothalamic stimulation activates ipsilateral trigeminal complex, but with no immediate perceived sensation within the trigeminal distribution. Other studies on the pain threshold in chronically stimulated patients showed increased threshold for cold pain in the distribution of the first trigeminal branch ipsilateral to stimulation. These studies suggest that activation of the hypothalamus and of the trigeminal system are both necessary, but not sufficient to generate CH attacks. In addition to the hypothalamus, other unknown brain areas are likely to play a role in the pathophysiology of this illness. Hypothalamus implantation is associated with a small risk of intracerebral haemorrhage and must be performed by an expert neurosurgical team, in selected patients.

AB - Cluster headache (CH) is a short-lasting unilateral headache associated with ipsilateral craniofacial autonomic manifestations. A positron emission tomography (PET) study has shown that the posterior hypothalamus is activated during CH attacks, suggesting that hypothalamic hyperactivity plays a key role in CH pathophysiology. On this basis, stimulation of the ipsilateral posterior hypothalamus was hypothesized to counteract such hyperactivity to prevent intractable CH. Ten years after its introduction, hypothalamic stimulation has been proved to successfully prevent attacks in more than 60% of 58 hypothalamic implanted drug-resistant chronic CH patients. The implantation procedure has generally been proved to be safe, although it carries a small risk of brain haemorrhage. Long-term stimulation is safe, and nonsymptomatic impairment of orthostatic adaptation is the only noteworthy change. Microrecording studies will make it possible to better identify the target site. Neuroimaging investigations have shown that hypothalamic stimulation activates ipsilateral trigeminal complex, but with no immediate perceived sensation within the trigeminal distribution. Other studies on the pain threshold in chronically stimulated patients showed increased threshold for cold pain in the distribution of the first trigeminal branch ipsilateral to stimulation. These studies suggest that activation of the hypothalamus and of the trigeminal system are both necessary, but not sufficient to generate CH attacks. In addition to the hypothalamus, other unknown brain areas are likely to play a role in the pathophysiology of this illness. Hypothalamus implantation is associated with a small risk of intracerebral haemorrhage and must be performed by an expert neurosurgical team, in selected patients.

KW - Chronic cluster headache

KW - Deep stimulation

KW - Drug-resistant

KW - Hypothalamus

KW - Neuromodulation

KW - Neurostimulation

KW - Trigeminal autonomic cephalgias

UR - http://www.scopus.com/inward/record.url?scp=77953457012&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953457012&partnerID=8YFLogxK

U2 - 10.1177/1756285610370722

DO - 10.1177/1756285610370722

M3 - Article

C2 - 21179610

AN - SCOPUS:77953457012

VL - 3

SP - 187

EP - 195

JO - Therapeutic Advances in Neurological Disorders

JF - Therapeutic Advances in Neurological Disorders

SN - 1756-2856

IS - 3

ER -